drugset / Trial / NCT01408173
Clinical Study of Caffeine for Apnea of Prematurity
NaSingle-groupOpen-labelTreatment
Summary
The aim of the present Phase III study is to evaluate the safety, efficacy and pharmacokinetics of Caffeine Citrate for treatment of apnea of prematurity in Japan.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NPC-11 | Unknown | 5 mg/kg | Intravenous |